RecruitingNCT06866912
Observational Epidemiological Study of Patients Suffering From Systemic Amyloidosis
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment
750 participants
Start Date
Sep 1, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
observational epidemiological study of patients affected by systemic amyloidosis
Eligibility
Min Age: 18 YearsMax Age: 99 Years
Inclusion Criteria3
- patients diagnosed with amyloidosis or asymptomatic carriers of mutations in the transthyretin gene
- minimum age of 18 years at the time of diagnosis
- obtaining informed consent
Exclusion Criteria1
- nothing
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06866912
Related Trials
A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter
NCT071165256 locations
TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer
NCT055078792 locations
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
NCT029626611 location
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
NCT0696446413 locations
Community Exercise Treating Effect on Cardiopulmonary Disease Patients
NCT071543551 location